A Phase I clinical trial: Use of 4-demethyl-4-cholesteryl-oxycarbonyl-penclomedine (DM-CHOC-PEN) plus radiation as treatments for cancers involving the CNS Article

Full Text via DOI: 10.1158/1538-7445.AM2019-CT065 Web of Science: 000488129900059

Cited authors

  • Weiner, R. S.; Mahmood, T.; Morgan, Lee Roy; Harris, K.; Baghian, A.; DiBiase, S. J.; Friedlander, P.; Ware, M. L.; Kawauchi, R.; Herman, J.; Bhandari, M.

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0008-5472


  • 79


  • 13